设为首页 中国市场调查彩票平台app下载网 关于彩票平台app下载网 购买流程
彩票平台app下载网
首页 > 英文报告> Report on China’s Veterinary Biologics Industry Investment

Report on China’s Veterinary Biologics Industry Investment

【报告名称:】

Report on China’s Veterinary Biologics Industry Investment

【关 键 词:】

Veterinary Biologics Industry Investment Report

【报告格式:】PDF或Word格式
【释放日期:】2012年6月
【交付方式:】特快专递或Email电子版
【英文版价格:】英文版:25000元
分享到:
报告描述

The scale of China’s veterinary farming industry keeps on increase in a high-density farming pattern, which will make the prevention of veterinary epidemics in China become increasingly severe. As biological products are more and more widely used in veterinary farming industry, China’s veterinary biologics industry develops rapidly. Since the breaking up of SARS in 2003 and the bird flu in 2004, China’s veterinary biologics industry has seen increasing prosperity, and the market of veterinary biological products in China has also seen an average growth rate of over 30%, which is much higher than the average global growth rate of 8%. In October, 2010, the State Council passed through discussion the Vaccine Supply System Construction Plan, which said that the central finance would provide support to the production of vaccines demanded by the national immune plan, and arranged about 9.4 billion Yuan for the investment into key projects. Besides, the scope of free compulsory immunization supported by the government was also expected to get further enlarged. Supported by a series of favorable policies, China’s veterinary biologics industry attracted the attention of much capital.
However, with the increase of China’s veterinary biological products enterprises and the constant rise of cost in the aspects of production, circulation and marketing, the competition in China’s veterinary biologics industry is also becoming increasingly fierce. Therefore, with such a condition, it is of great importance to have a comprehensive and overall learning of the market conditions of the industry. For example, what is the orientation of the national policies and regulations in the industry? What is the direction and structure of competition in the industry? What are the circulation channels of China’s veterinary biological products? Which veterinary biological products enterprises are of investment value? How should we help the targeted enterprises make correct development strategies so that the enterprises may get ahead in the competitive veterinary drug market?
This report will provide a detailed analysis of the above questions and, on the basis of an exposition about the status quo of China’s veterinary biologics industry in 2011, make an in-depth analysis of the development environment, enterprises structure and scale, as well as the circulation and marketing of China’s veterinary biologics industry. Besides, the report will also make a detailed and objective analysis of the development trend of China’s veterinary biologics industry, aiming to be of help to the scientific judgment of the investment value of China’s veterinary biologics industry.
This report is written with meticulous care based on data from national authoritative departments and industry associations, including the National Bureau of Statistics, Development Research Center of the State Council, National Development and Reform Commission, General Administration of Customs, State Information Center, the Ministry of Commerce, the Ministry of Agriculture, China Institute of Veterinary Drugs Control, China Veterinary Drug Association and China Veterinary Agriculture Association, etc., and therefore conveys much scientific and far-sighted insight with the accurate and authoritative data.

报告目录

1 China’s Veterinary Biologics Industry Development Course and Direction
1.1China’s Veterinary Biologic Industry Development Course
1.2Position and Market Share of Biological Products in China’s Veterinary Heath-care Industry
1.3 Comparison between Global and China’s Veterinary Biologics Industry
1.4 China’s Veterinary Biologic Industry Development Direction
2 Policy Environment of China’s Veterinary Biologics Industry
2.1 Production Policy for China’s Veterinary Biologic Industry (including taxation, supporting policy and subsidy policy)
2.2 Planning of China’s Veterinary Biologic Industry
2.3 Impact of Compulsory Immunization Policy on China’s Veterinary Biologic Industry
2.4 Trade Policy for China’s Veterinary Biologic Industry
2.5 Circulation Policy for China’s Veterinary Biologic Industry
2.6 Impact of China’s Veterinary Biologic Industry Policy on Future Industry Development
3 Market Scale and Development Trend of China’s Veterinary Biologics Industry
3.1Scale of China’s Veterinary Biological Products by Types
3.1.1 Market Scale of Compulsory Immunization Vaccine
3.1.2 Market Scale of Domestic-produced Conventional Vaccine
3.1.3 Market Scale of Imported Conventional Vaccine (China’s Import of Veterinary Biologics and Scale)
3.2 China’s Hog Biological Products Market Scale and Estimation
3.2.1 Occurrence of Hog Diseases and Development Trend in China
3.2.2 Status quo of China’s Hog Biological Products Utility and Market Demand
3.2.3 Major Products and Market Share of China’s Hog Biological Products
3.2.4 Estimation of China’s Hog Biological Products Market Growth(2009-2016)
3.3China’s Poultry Biological Products Market Scale and Estimation
3.3.1 Occurrence of Poultry Diseases and Development Trend in China
3.3.2 Status quo of China’s Poultry Biological Products Utility and Market Demand
3.3.3 Major Products and Market Share of China’s Poultry Biological Products
3.3.4 Estimation of China’s Poultry Biological Products Market Growth (2009-2016)
3.4 China’s Ruminant Veterinary Biological Products Market Scale and Estimation
3.4.1 Occurrence of Ruminant Animal Diseases and Development Trend in China
3.4.2 Status quo of China’s Ruminant Veterinary Biological Products Utility and Market Demand
3.4.3 Major Products and Market Share of China’s Ruminant Veterinary Biological Products
3.4.4 Estimation of China’s Ruminant Veterinary Biological Products Market Growth (2009-2016)
3.5 China’s Aquatic Veterinary Biological Products Market Scale and Estimation
3.5.1 Occurrence of Aquatic Animal Diseases and Development Trend in China
3.5.2 Status quo of China’s Aquatic Veterinary Biological Products Utility and Market Demand
3.5.3 Major Products and Market Share of China’s Aquatic Veterinary Biological Products
3.5.4 Estimation of China’s Aquatic Veterinary Biological Products Market Growth (2009-2016)
3.6 China’s Pet Veterinary Biological Products Market Scale and Estimation
3.6.1 Occurrence of Pet Animal Diseases and Development Trend in China
3.6.2 Status quo of China’s Pet Veterinary Biological Products Utility and Market Demand
3.6.3 Major Products and Market Share of China’s Pet Veterinary Biological Products
3.6.4 Estimation of China’s Pet Veterinary Biological Products Market Growth (2009-2016)
4 Analysis of China’s Veterinary Biologics Industry Chain
4.1 Research and Development (R&D)
4.1.1 Major Research Institutions of Veterinary Biological Products in China
4.1.2 Technical R & D Capability of China’s Veterinary Biologics Industry
4.1.3 Mechanism of Technical R&D Investment in Veterinary Biologics Industry in China
4.2 Production
4.2.1 Output Capacity and Output Value of China’s Veterinary Biological Products Market
4.2.2 Production Profit of China’s Veterinary Biologics Industry
4.2.3 Price Trend of China’s Major Veterinary Biological Products
4.2.3.1 Price Trend of China’s Major Hog Veterinary Biological Products
4.2.3.2 Price Trend of China’s Major Poultry Veterinary Biological Products
4.2.4 Structure and Locations of China’s Major Veterinary Biologics Enterprises
4.2.5 Concentration of China’s Veterinary Biological Products Market
4.3 Circulation
4.3.1 Circulation Pattern of China’s Veterinary Biological Products
4.3.2 Analysis of Marketing Channels of China’s Veterinary Biological Products
4.3.3 Analysis of Profit Distribution in China’s Veterinary Biological Products Circulation
4.3.3.1 The Marketing Pattern and Cost Structure of the Total Distributor
4.3.3.2 The Marketing Pattern and Cost Structure of Level I Distributor
4.3.3.3 The Marketing Pattern and Cost Structure of Direct Distributor
4.3.3.4 Analysis of Profit Distribution among Distributors at Different Levels
4.3.4 Major Marketing Patterns and Customer Strategies of China’s Veterinary Biological Products
4.3.5 The Impact of GSP on the Circulation and Marketing of China’s Veterinary Biological Products
4.4 Overall Evaluation of China’s Veterinary Biologics Industry Chain
5 Analysis of Investment Opportunities and Directions in China’s Veterinary Biologics Industry
5.1 Analysis of Investment Opportunities and Directions in China’s Hog Veterinary Biological Products
5.2 Analysis of Investment Opportunities and Directions in China’s Poultry Veterinary Biological Products
5.3 Analysis of Investment Opportunities and Directions in China’s Ruminant Veterinary Biological Products
5.4 Analysis of Investment Opportunities and Direction sin China’s Aquatic Veterinary Biological Products
5.5 Analysis of Investment Opportunities and Directions in China’s Pet Veterinary Biological Products
5.6 Analysis of Investment Opportunities and Directions in China’s Other Veterinary Biological Products
6 Analysis of the Investment Risks in China’s Veterinary Biologics Industry
6.1 Risk of Low R&D Capability
6.2 Risk of Intellectual Property Protection
6.3 Risk of Products Quality Control
6.4 Risk of Severe Animal Diseases
6.5 Risk of Shortage of Service Capability and Human Resources
6.6 Risk of Market Competition
7 Analysis of Key Enterprises in China’s Veterinary Biologics Industry
7.1 Analysis of Listed Enterprises
7.1.1 CAHIC (China Animal Husbandry Industry Co., Ltd)
7.1.1.1 Enterprise Profile
? 7.1.1.2 Time of Getting Listed, Offering Price and Price-Earnings Ratio
? 7.1.1.3 Sales Revenue, Profit and Trend of Share Prices
? 7.1.1.4 Constitution of Major Business/ Products/Service
7.1.2 TCSW
7.1.2.1 Enterprise Profile
? 7.1.2.2 Time of Getting Listed, Offering Price and Price-Earnings Ratio
? 7.1.2.3 Sales Revenue, Profit and Trend of Share Prices
? 7.1.2.4 Constitution of Major Business/ Products/Service
7.1.3 Inner Mongolia Jinyu Group Co., Ltd.
7.1.3.1 Enterprise Profile
? 7.1.3.2 Time of Getting Listed, Offering Price and Price-Earnings Ratio
? 7.1.3.3 Sales Revenue, Profit and Trend of Share Prices
? 7.1.3.4 Constitution of Major Business/ Products/Service
7.1.4 Ringpu Biology
7.1.4.1 Enterprise Profile
? 7.1.4.2 Time of Getting Listed, Offering Price and Price-Earnings Ratio
? 7.1.4.3 Sales Revenue, Profit and Trend of Share Prices
? 7.1.4.4 Constitution of Major Business/ Products/Service
7.2 Analysis of Enterprises not listed (Including names and profile of top 10 enterprises, major products and market shares, sales revenue, operation pattern, and judgment on investment value, etc. )
7.2.1Analysis of China’s Top 10 Hog Veterinary Biological Products Enterprises
7.2.2 Analysis of China’s Top 10 Poultry Veterinary Biological Products Enterprises
7.3 Selection and Analysis of China’s Other Veterinary Biological Products Enterprises (Including names and profile of the enterprises, major products and market shares, sales revenue, operation pattern, and judgment on investment value, et.)
8 Major Foreign-Invested Enterprises and Analysis of Their Market Competitiveness
8.1 Pfizer/ Fort Dodge
8.1.1 Profile of China Branch
8.1.2 Sales Revenue
8.1.3 Major Products and Market Share
8.1.4 Analysis of Its Competitiveness in Chinese Market

8.2 Boehringer Ingelheim
8.2.1 Profile of China Branch
8.2.2 Sales Revenue
8.2.3 Major Products and Market Share
8.2.4 Analysis of Its Competitiveness in Chinese Market

8.3 Merial
8.3.1 Profile of China Branch
8.3.2 Sales Revenue
8.3.3 Major Products and Market Share
8.3.4 Analysis of Its Competitiveness in Chinese Market

8.4 Bayer
8.4.1 Profile of China Branch
8.4.2 Sales Revenue
8.4.3 Major Products and Market Share
8.4.4 Analysis of Its Competitiveness in Chinese Market

8.5 Novartis
8.5.1 Profile of China Branch
8.5.2 Sales Revenue
8.5.3 Major Products and Market Share
8.5.4 Analysis of Its Competitiveness in Chinese Market

8.6 Hipra
8.6.1 Profile of China Branch
8.6.2 Sales Revenue
8.6.3 Major Products and Market Share
8.6.4 Analysis of Its Competitiveness in Chinese Market

8.7 Intervet / Schering-Plough
8.7.1 Profile of China Branch
8.7.2 Sales Revenue
8.7.3 Major Products and Market Share
8.7.4 Analysis of Its Competitiveness in Chinese Market

8.8 Lohmann
8.8.1 Profile of China Branch
8.8.2 Sales Revenue
8.8.3 Major Products and Market Share
8.8.4 Analysis of Its Competitiveness in Chinese Market

8.9 U.S. PeproTech
8.9.1 Profile of China Branch
8.9.2 Sales Revenue
8.9.3 Major Products and Market Share
8.9.4 Analysis of Its Competitiveness in Chinese Market

8.10 Italy Ascor Chimici Srl
8.10.1 Profile of China Branch
8.10.2 Sales Revenue
8.10.3 Major Products and Market Share
8.10.4 Analysis of Its Competitiveness in Chinese Market
NO:12-22 

彩票平台app下载网电话订购

电 话: 56287808
传 真:010-87661981
E_mail:cnscdc@hjsdicr.com

彩票平台app下载网在线订购

MSN:
scdcbg@hotmail.com
lixin8866@hotmail.com
市场调查网QQ

订购流程

为什么选择我们


相关链接